Publications by authors named "A Hockaday"

Claim this Profile
R
Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials Unit.
F Slevin, E M Hudson, A Hockaday, J Kendall, S Noutch

Clin Oncol (R Coll Radiol)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Talha Munir, Sean Girvan, David A Cairns, Adrian Bloor, David Allsup, Anna Hockaday

N Engl J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Gordon Cook, A John Ashcroft, Ethan Senior, Catherine Olivier, Anna Hockaday

Lancet Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Freshwater wetlands for flood control: How manipulating the hydroperiod affects plant and invertebrate communities.
Alyssa C Hockaday, Arturo S Leon, Kyle Patterson, Steven C Pennings

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.
Ruth M de Tute, Gordon Cook, David A Cairns, Julia M Brown, Jamie Cavenagh, Anna Hockaday

Bone Marrow Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis